China Resources Pharmaceutical Group Ltd.
3320
株式のランク
#4289
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
株価
$0.58782103
時価総額
$3.69B
変化（1日）
-1.29%
変化（1年）
-4.63%
国
HK
取引 China Resources Pharmaceutical Group Ltd. (3320)
カテゴリー
Healthcare
China Resources Pharmaceutical Group Ltd.（3320）の発行済株式数
June 2026 時点の発行済株式数 6.28B
China Resources Pharmaceutical Group Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 6.28B です。December 2023 の終わりには、同社は 6.28B 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
China Resources Pharmaceutical Group Ltd.（3320）の発行済株式数の履歴（2013 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 6.28B | 0.00% |
| 2024 | 6.28B | 0.00% |
| 2023 | 6.28B | 0.00% |
| 2022 | 6.28B | 0.00% |
| 2021 | 6.28B | -0.01% |
| 2020 | 6.28B | -0.02% |
| 2019 | 6.28B | 0.00% |
| 2018 | 6.28B | 0.00% |
| 2017 | 6.28B | 27.93% |
| 2016 | 4.91B | 6.11% |
| 2015 | 4.63B | -25.00% |
| 2014 | 6.17B | 0.00% |
| 2013 | 6.17B | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 445.06M | -92.92% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | -98.32% |
US
|
